Aiding and ABT’ing Treatment for Glioblastoma

Cancer Biology and Therapy - United States
doi 10.4161/cbt.6.5.4431
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Efficacy and Safety of Bevacizumab for the Treatment of Glioblastoma

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2015English

Current State of Immunotherapy for Treatment of Glioblastoma

Current Treatment Options in Oncology
OncologyPharmacology
2019English

EANO Guideline for the Diagnosis and Treatment of Anaplastic Gliomas and Glioblastoma

The Lancet Oncology
Oncology
2014English

Agent-Based Aiding for Individual and Team Planning Tasks

Proceedings of the Human Factors and Ergonomics Society Annual Meeting
2000English

Mean-Clustered ADC Metrics for Assessing Treatment Response in Glioblastoma

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

Nutlin-Loaded Magnetic Solid Lipid Nanoparticles for Targeted Glioblastoma Treatment

Nanomedicine
DevelopmentMaterials ScienceNanoscienceMedicineBioengineeringNanotechnologyBiomedical Engineering
2019English

Cell Death-Based Treatment of Glioblastoma

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2018English

Soldier Tracking, Identification and Aiding System

International Journal of Advanced Research in Electrical, Electronics and Instrumentation Engineering
2015English

The Rationale and Methodology for Intra-Arterial Chemotherapy With BCNU as Treatment for Glioblastoma

Journal of Neurosurgery
SurgeryNeurology
1985English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy